WHEN: FRI, oct 25 // 12:05-1:05 PM

WHERE: SEAPORT BALLROOM // MEZZANINE LEVEL (2)

Bristol Myers Squibb

A Contemporary Case-based Discussion of Cardiac Myosin Inhibition for the Management of NYHA Class II-III Symptomatic Obstructive HCM Patients

*On-Demand / Enduring: Not Available*

This presentation will include the most recent long-term, real-world, and REMS data on cardiac myosin inhibition. A patient case will be discussed highlighting the diagnosis, initiation, and journey on cardiac myosin inhibition. 

Speakers:

 
 

MARIKO HARPER, MD

Virginia Mason Franciscan Health

MATTHEW MARTINEZ, MD

Atlantic Health System